Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,624
Total Claims
$366K
Drug Cost
631
Beneficiaries
$581
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 3,186 Anesthesiology providers
+78%
Opioid rate vs peers
61.9% vs 34.8% avg
+38%
Cost per patient vs peers
$581 vs $422 avg
+56%
Brand preference vs peers
7.4% vs 4.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
61.9%
Opioid Rate
3,484
Opioid Claims
$269K
Opioid Cost
26.6%
Long-Acting Rate
This provider's opioid prescribing rate of 61.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 416 claims · $208K
Generic: 5,208 claims · $158K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl | 112 | $108K |
| Oxycodone Myristate | 39 | $33K |
| Hydrocodone/Acetaminophen | 1,064 | $24K |
| Diclofenac Sodium | 44 | $21K |
| Fentanyl | 200 | $19K |
| Buprenorphine Hcl | 13 | $18K |
| Oxycodone Hcl/Acetaminophen | 479 | $14K |
| Morphine Sulfate | 403 | $14K |
| Oxycodone Hcl | 353 | $9,834 |
| Erenumab-Aooe | 12 | $9,480 |
| Gabapentin | 534 | $9,340 |
| Lidocaine | 50 | $7,551 |
| Buprenorphine | 23 | $7,067 |
| Oxymorphone Hcl | 11 | $6,632 |
| Hydromorphone Hcl | 298 | $4,223 |
Prescribing Profile
48
Unique Drugs
21.0
Anomaly Score
Patient Profile
69
Avg Age
68%
Female
1.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data